Picture of Fagron NV logo

FAGR Fagron NV News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareConservativeMid CapHigh Flyer

Brief: Fagron Q3 Turnover Grows 10.7% CER To EUR 135.1 Million

Oct 13 (Reuters) - Fagron NV  FAGRO.BR :
    * Q3-2020: TURNOVER GROWTHOF 10.7% CER TO EUR 135.1 MILLION
    * STRONG PERFORMANCE, PARTICULARLY IN LATIN AMERICA; NORTH AMERICA ALSO REPORTS GOOD GROWTH
IN
TURNOVER
    * SIGNIFICANT WEAKENING OF BRL AND MXN AGAINST EUR RESULTS IN REPORTED TURNOVER DECLINE OF
0.4% IN
Q3
    * IMPACT OF COVID-19 PANDEMIC REMAINED LIMITED AND NON-MATERIAL IN Q3
    * ACQUISITION OF PHARMA TAMAR IN ISRAEL COMPLETED IN AUGUST
    * THERE HAVE BEEN VIRTUALLY NO DISRUPTIONS TO FAGRON’S SUPPLY CHAIN AS A RESULT OF COVID-19
    * COMING QUARTER WILL ALSO BE DOMINATED BY COVID-19 AND VISIBILITY IS LIMITED

Source text for Eikon:  ID:nGNE3vzh1J 
Further company coverage:  FAGRO.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Fagron NV

See all news